Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firms withdraw adulterated products

This article was originally published in The Tan Sheet

Executive Summary

Genetic Edge Technologies, Advanced Muscle Science, Fizogen Precision Technologies and KiloSports recall bodybuilding products marketed as supplements after FDA warned the firms the week of Sept. 12 their prescription aromatase inhibitor ingredients do not qualify as dietary ingredients. FDA notified consumers of potential adverse events associated with ATD and other aromatase inhibitors, including decreased rate of bone maturation and growth, decreased sperm production, infertility, aggressive behavior, adrenal insufficiency, kidney failure and liver dysfunction. Consumers with liver, kidney, adrenal or prostate abnormalities are at increased risk. Phoenix-based G.E.T. and KiloSports recalled 60-count bottles of Arimadex and Clomed products, respectively. Fizogen of Wellington, Fla., and AMS of Silver Spring, Nev., recalled the previously discontinued Off Cycle II Hardcore and Arom-X products, respectively, that may still be sold by online retailers, FDA said

Related Content

Novedex recalled
iForce recalls "hormonal regulation" supplement





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts